
The company introduces Gut & Protein Optimizer, a probiotic-enzyme formula for protein utilization, and NMN 300 mg, an NAD+ precursor.
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran.
Decas Botanical Synergies (Carver, MA) announced the publication of a
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran. The company says that at the end of the treatment period, results showed a significant reduction in the presence of E. coli and support for urinary tract health.






